Ronald Swartz, MD
Urology · New Orleans, LANPI 1124126594
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $407, 7.7 times the $53 reported in 2019. That places this record below the midpoint for urology clinicians in LA, where the typical reported total is $2,723.
Across 56 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$240
- Sumitomo Pharma America, Inc.$177
- Urogen Pharma, Inc.$137
- Progenics Pharmaceuticals, Inc.$103
- Johnson & Johnson$96
- Pfizer$88
- plus $458 from 13 others
What the payments were for
- Food & beverage$1,300100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $240 |
| Sumitomo Pharma America, Inc. | 9 | $177 |
| Urogen Pharma, Inc. | 5 | $137 |
| Progenics Pharmaceuticals, Inc. | 3 | $103 |
| Johnson & Johnson | 4 | $96 |
| Pfizer | 4 | $88 |
| Boston Scientific | 1 | $65 |
| Merck | 2 | $52 |
| ABC Home Medical Supply, Inc. | 3 | $51 |
| Halozyme Inc | 2 | $47 |
| 180 Medical, Inc. | 2 | $46 |
| Hollister Incorporated | 2 | $40 |
| Antares Pharma, Inc. | 2 | $37 |
| Urovant Sciences Inc | 2 | $27 |
| Cook Medical LLC | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Civco Medical Instruments | 1 | $18 |
| Axonics, Inc. | 1 | $17 |
| Dendreon Pharmaceuticals LLC | 1 | $16 |
How this compares
$1,300 in reported general payments places this provider in the 30th percentile of 199 urology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 85 | $71,780 |
| GemtesaVibegron | 51 | $56,950 |
| Tamsulosin Hcl | 267 | $2,814 |
| Finasteride | 93 | $1,026 |
| Dutasteride | 22 | $1,003 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $513 |
| Solifenacin Succinate | 18 | $481 |
| Bicalutamide | 11 | $400 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $382 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $342 |
| CefuroximeCefuroxime Axetil | 21 | $329 |
| Ciprofloxacin Hcl | 32 | $288 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $194 |
| Fluconazole | 22 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $240 | $71,78085 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $177 | $56,95051 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 199 urology providers in Louisiana.
Other urology in New Orleans
- Richard VanlangendonckNew Orleans$289K
- Wayne HellstromNew Orleans$183K
- Colin GoudelockeNew Orleans$124K
- Raju ThomasNew Orleans$67K
- Louis KraneNew Orleans$62K
- Jorge CasoNew Orleans$54K
- Lawrence JenkinsNew Orleans$33K
- Alexis ChesrowNew Orleans$17K
- Joanna TogamiNew Orleans$10K
- Neil BaumNew Orleans$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.